Amdocs had its Relative Strength (RS) Rating upgraded from 70 to 73 Tuesday — a welcome improvement, but still shy of the 80 or higher score you prefer to see.
IBD's unique RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks compares to the rest of the market.
Over 100 years of market history shows that the market's biggest winners often have an 80 or better RS Rating as they begin their largest price moves. See if Amdocs can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Amdocs is building a flat base with a 93.34 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal.
The company showed 6% EPS growth last quarter. Revenue increased -11%.
Amdocs holds the No. 13 rank among its peers in the Computer-Technical Services industry group. IBEX, Dave and Innodata are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
